CV Sciences (CVSI) Cash from Financing Activities (2011 - 2026)

CV Sciences has disclosed Cash from Financing Activities across 16 years of filings, most recently posting -$68000.0 for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$68000.0, down 114.17% year-over-year; the trailing twelve-month figure through Mar 2026 was -$211000.0 (down 132.56% YoY), and the FY2025 annual result was $337000.0, up 953.12% from the prior year.
• Cash from Financing Activities came in at -$68000.0 for Q1 2026 at CV Sciences, down from $258000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $1.4 million in Q1 2022 to a low of -$872000.0 in Q1 2023.
• The 5-year median for Cash from Financing Activities is -$87000.0 (2024), against an average of $1823.5.
• Peak annual rise in Cash from Financing Activities reached 2207.14% in 2024, while the deepest fall reached 498.21% in 2024.
• CV Sciences' Cash from Financing Activities stood at -$738000.0 in 2022, then soared by 92.41% to -$56000.0 in 2023, then slumped by 498.21% to -$335000.0 in 2024, then jumped by 177.01% to $258000.0 in 2025, then tumbled by 126.36% to -$68000.0 in 2026.
• The last three Cash from Financing Activities figures came in at -$68000.0 (Q1 2026), $258000.0 (Q4 2025), and -$234000.0 (Q3 2025), per Business Quant data.